Blueprint Medicines Vs. Dave Industry Stock Comparison

Sell

28

BPMC
Blueprint Medicines

Last Price:

$88.45

Seasonality Move:

1.24%

Buy

79

DAVE
Dave

Last Price:

$89.93

Seasonality Move:

87.09%

Sell

28

Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

The current Blueprint Medicines [BPMC] share price is $88.35. The Score for BPMC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

79

Dave (DAVE) is a Buy

Is Dave a Buy, Sell or Hold?

The current Dave [DAVE] share price is $89.87. The Score for DAVE is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
DAVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

The Blueprint Medicines share price today is $88.35

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

DAVE Stock Price Chart

What is Dave's stock price today?

The Dave share price today is $89.87

The current trend is moderately bullish and DAVE is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.67	Sell
Relative Strength Index (14 RSI):	41.43	Sell
Chaikin Money Flow:	145602	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(89.34 - 96.06)	Sell
Bollinger Bands (100):	(87.25 - 95.63)	Sell

DAVE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.46	Buy
Relative Strength Index (14 RSI):	52.27	Buy
Chaikin Money Flow:	230735	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(86 - 96.94)	Sell
Bollinger Bands (100):	(33.53 - 81.33)	Buy

BPMC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	88.93	Sell
20-day SMA:	91.77	Sell
50-day SMA:	92.58	Sell
200-day SMA:	96.69	Sell
8-day EMA:	88.86	Sell
20-day EMA:	90.87	Sell
50-day EMA:	92.12	Sell
200-day EMA:	91.53	Sell

DAVE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	92.67	Sell
20-day SMA:	91.33	Sell
50-day SMA:	75.49	Buy
200-day SMA:	48.04	Buy
8-day EMA:	91.08	Sell
20-day EMA:	89.83	Buy
50-day EMA:	78.42	Buy
200-day EMA:	51.17	Buy

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $2.93 per share.

Dave Earnings Growth & DAVE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $1.12 per share.

Blueprint Medicines Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dave Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):